Intercept Pharmaceuticals Announces Pricing of Public Offering
[GlobeNewswire] – NEW YORK — Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver … moreView todays social media effects on ICPTView the latest stocks trending across Twitter. Click to view dashboardSee who Intercept is hiring next, click here to view […]